Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 04, 2025 13:50 ET | Source: Block & Leviton LLP

BREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed 10-K and KPMG Evaluation of Controls

Block & Leviton is investigating ADMA Biologics for potential securities fraud. Investors who lost money in ADMA should contact the firm to learn more.
October 17, 2024 11:00 ET | Source: Block & Leviton LLP

ADMA Biologics ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

Block & Leviton is investigating ADMA Biologics (Nasdaq: ADMA) for potential securities fraud. Investors who have lost money should contact the firm.
October 10, 2024 14:44 ET | Source: Block & Leviton LLP

ADMA Biologics Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm’s Investigation

Block & Leviton is investigating ADMA Biologics for potential securities law violations. Investors who have lost money in ADMA should contact the firm.